欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0320/002
药品名称
Lisinopril e Idroclorotiazide GIT
活性成分
hydrochlorothiazide 12.5 mg
lisinopril 20.0 mg
剂型
Tablet
上市许可持有人
SF Group Srl Via Tiburtina 1143 00156 Roma Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
许可日期
2008/08/08
最近更新日期
2022/02/08
药物ATC编码
C09BA03 lisinopril and diuretics
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
common_pil_clean
Date of last change:2024/09/06
Final SPC
|
common_pil_clean_2
Date of last change:2024/09/06
Final Product Information
|
common_pil_clean_3
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean
Date of last change:2024/09/06
Final Product Information
|
notification of acceptable submission
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase